Atara Biotherapeutics Inc
ATRAHealthcare|Biotechnology|USA
$9.72
-0.26 (-2.59%)
About
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Stock Price
+2.5%(1Y)
Pipeline Summary
11 total trials7
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
NO_LONGER_AVAILABLE: 2Terminated: 3Withdrawn: 1Completed: 4Active: 1
Active Trials (1)
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
NCT04577326Malignant Pleural Mesothelioma (MPM)
Phase 1Active
Enrollment: 14 participants
BioScore
4.7/10
Cautious
Ownership
Recent Insider Trades
Nguyen AnhCoSELL
2026-05-185,241 shares @ $9.13
Grant-Huerta YaninaSELL
2026-05-182,414 shares @ $9.13
EcoR1 Capital, LLCBUY
2026-05-07507,407 shares @ $9.35
Panacea Innovation LtdSELL
2026-05-07313,446 shares @ $10.1
Grant-Huerta YaninaSELL
2026-03-022,104 shares @ $5.08
Data last updated: Jul 13, 2026, 12:50 PM